NO920193L - Fremgangsmaate for fremstilling av aspartam fra et diketopiperazin og nye mellomprodukter og derivater derfor - Google Patents

Fremgangsmaate for fremstilling av aspartam fra et diketopiperazin og nye mellomprodukter og derivater derfor

Info

Publication number
NO920193L
NO920193L NO92920193A NO920193A NO920193L NO 920193 L NO920193 L NO 920193L NO 92920193 A NO92920193 A NO 92920193A NO 920193 A NO920193 A NO 920193A NO 920193 L NO920193 L NO 920193L
Authority
NO
Norway
Prior art keywords
derivatives
aspartam
diketopiperazine
procedure
preparation
Prior art date
Application number
NO92920193A
Other languages
English (en)
Norwegian (no)
Other versions
NO920193D0 (no
Inventor
John B Hill
Tse-Lok Ho
Mark R Johnson
Russell Klix
Gayle Webber
Robert A Erickson
Original Assignee
Nutrasweet Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrasweet Co filed Critical Nutrasweet Co
Publication of NO920193D0 publication Critical patent/NO920193D0/no
Publication of NO920193L publication Critical patent/NO920193L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • C07K5/06113Asp- or Asn-amino acid
    • C07K5/06121Asp- or Asn-amino acid the second amino acid being aromatic or cycloaliphatic
    • C07K5/0613Aspartame
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO92920193A 1990-03-15 1992-01-15 Fremgangsmaate for fremstilling av aspartam fra et diketopiperazin og nye mellomprodukter og derivater derfor NO920193L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US49824390A 1990-03-15 1990-03-15
US60665690A 1990-10-31 1990-10-31
US65878491A 1991-02-26 1991-02-26
US66480691A 1991-03-08 1991-03-08
PCT/US1991/001646 WO1991014378A1 (en) 1990-03-15 1991-03-12 Process for manufacturing aspartame from a diketopiperazine and novel intermediates and derivatives therefor

Publications (2)

Publication Number Publication Date
NO920193D0 NO920193D0 (no) 1992-01-15
NO920193L true NO920193L (no) 1992-01-15

Family

ID=27504394

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92920193A NO920193L (no) 1990-03-15 1992-01-15 Fremgangsmaate for fremstilling av aspartam fra et diketopiperazin og nye mellomprodukter og derivater derfor

Country Status (16)

Country Link
EP (1) EP0478729B1 (de)
CN (1) CN1057835A (de)
AT (1) ATE141613T1 (de)
AU (1) AU628257B2 (de)
CA (1) CA2060515A1 (de)
CS (1) CS70091A2 (de)
DE (1) DE69121502T2 (de)
DK (1) DK0478729T3 (de)
ES (1) ES2091324T3 (de)
GR (1) GR3020839T3 (de)
HU (1) HUT60712A (de)
IE (1) IE910896A1 (de)
NO (1) NO920193L (de)
NZ (1) NZ237469A (de)
PT (1) PT97049B (de)
WO (1) WO1991014378A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04234375A (ja) * 1990-12-27 1992-08-24 Ajinomoto Co Inc 新規2,5−ジオキソピペラジン化合物及びその製造法
JPH04234374A (ja) * 1990-12-27 1992-08-24 Ajinomoto Co Inc ジケトピペラジン誘導体の製造方法
JPH05117246A (ja) * 1991-10-23 1993-05-14 Ajinomoto Co Inc 新規2,5−ジオキソピペラジン化合物とその製造法及びα−L−アスパルチル−L−フエニルアラニンメチルエステル誘導体の製造法
US6465677B1 (en) 1998-11-19 2002-10-15 The Nutrasweet Company Method for the preparation of N-neohexyl-α-aspartyl-L-phenylalanine methyl ester from imidazolidin-4-one intermediates
DE10019879A1 (de) * 2000-04-20 2001-10-25 Degussa Verfahren zur Herstellung von 2,5-Diketopiperazinen, neue 2,5-Diketopiperazine und deren Verwendung
CN100553636C (zh) 2000-08-04 2009-10-28 Dmi生物科学公司 二酮基哌嗪和包含它们的组合物的使用方法
GB2382346B (en) * 2000-08-04 2004-08-11 Dmi Biosciences Inc Method of synthesizing diketopiperazines
WO2004030522A2 (en) 2002-10-02 2004-04-15 Dmi Biosciences, Inc. Diagnosis and monitoring of diseases
EP2517718B1 (de) 2003-05-15 2016-03-02 Ampio Pharmaceuticals, Inc. Behandlung von T-Zell-vermittelten Krankheiten
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ,インコーポレイテッド ジケトピペラジンを用いた医薬組成物
EP2613786A4 (de) 2010-09-07 2013-10-23 Dmi Acquisition Corp Behandlung von erkrankungen
EA028343B1 (ru) 2011-10-10 2017-11-30 Ампио Фармасьютикалз, Инк. Лечение дегенеративного заболевания сустава
MY172699A (en) 2011-10-10 2019-12-10 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
EP2771007B1 (de) 2011-10-28 2018-04-04 Ampio Pharmaceuticals, Inc. Behandlung von rhinitis
BR112015020469A2 (pt) 2013-03-15 2020-01-28 Ampio Pharmaceuticals Inc Usos de da-dkp, composição e método para fornecimento de células-tronco a umindivíduo
RU2736513C2 (ru) 2014-08-18 2020-11-17 Ампио Фармасьютикалз, Инк. Лечение патологических состояний суставов
EP3310375A4 (de) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. Verwendung von niedermolekularen fraktionen von humanem serumalbumin bei der behandlung von erkrankungen
US11510427B2 (en) * 2016-12-21 2022-11-29 Suntory Holdings Limited Food and beverages containing cyclo(aspartyl-glycine), glucose, and maltose
JPWO2024075813A1 (de) * 2022-10-07 2024-04-11

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2038106A1 (de) * 1970-07-31 1972-02-10 Henkel & Cie Gmbh Aktivatoren fuer Perverbindungen
JPS58185545A (ja) * 1982-04-22 1983-10-29 Ajinomoto Co Inc α−L−アスパルチル−L−フエニルアラニンメチルエステルまたはその塩酸塩の製法
IT1197461B (it) * 1983-05-13 1988-11-30 Debi Derivati Biologici Procedimento per la preparazione dell'estere metilico di alfa-l-aspartil-l-fenil-alanina
JPS60174799A (ja) * 1984-02-21 1985-09-09 Ajinomoto Co Inc α−L−アスパルチル−L−フエニルアラニンメチルエステルの製造法
AU586669B2 (en) * 1985-03-29 1989-07-20 Mitsui Toatsu Chemicals Inc. Preparation process of ```-L-aspartyl-L-phenylalanine methyl ester or hydrochloride thereof
JPH0647600B2 (ja) * 1985-06-04 1994-06-22 味の素株式会社 β−アスパルチルフエニルアラニン誘導体のα−アスパルチルフエニルアラニン誘導体への変換法
US4677220A (en) * 1985-10-31 1987-06-30 Monsanto Company Process for the preparation of α-L-aspartyl-L-phenylalanine methyl ester
DE3600731A1 (de) * 1986-01-13 1987-07-16 Green Cross Korea Verfahren zur herstellung von (alpha)-l-aspartyl-l-phenylalaninmethylester
US4992552A (en) * 1988-08-31 1991-02-12 Eastman Kodak Company Process for preparation of amino acids

Also Published As

Publication number Publication date
NO920193D0 (no) 1992-01-15
DE69121502T2 (de) 1997-01-16
EP0478729A4 (en) 1993-06-16
EP0478729A1 (de) 1992-04-08
IE910896A1 (en) 1991-09-25
EP0478729B1 (de) 1996-08-21
AU7564891A (en) 1991-10-21
ES2091324T3 (es) 1996-11-01
AU628257B2 (en) 1992-09-10
CN1057835A (zh) 1992-01-15
HUT60712A (en) 1992-10-28
WO1991014378A1 (en) 1991-10-03
DE69121502D1 (de) 1996-09-26
NZ237469A (en) 1993-08-26
CS70091A2 (en) 1991-10-15
DK0478729T3 (da) 1996-09-16
GR3020839T3 (en) 1996-11-30
PT97049A (pt) 1991-12-31
CA2060515A1 (en) 1991-09-16
PT97049B (pt) 1998-07-31
ATE141613T1 (de) 1996-09-15

Similar Documents

Publication Publication Date Title
NO920193D0 (no) Fremgangsmaate for fremstilling av aspartam fra et diketopiperazin og nye mellomprodukter og derivater derfor
FI904204A0 (fi) Foerfarande foer framstaellning av cykliska aminosyraderivat och mellanprodukter.
DK158723C (da) Analogifremgangsmaade til fremstilling af triphenylimidazol-2-yloxyalkansyrer og derivater deraf
FR2667076B1 (fr) Procede et appareil pour la fabrication d'un aminoacide par fermentation.
NO902839L (no) Fremgangsmaate for rensing av tryptofan.
GR920100570A (el) Παραγωγα 3(2η)-πυριδαζινονης και μεθοδος για την παρασκευη τους.
NO177708C (no) Fremgangsmåte og mellomprodukter for fremstilling av oksoftalazinyl-eddiksyrer og analoger derav
DK0495953T3 (da) 10-(1-Hydroxyethyl)-11-oxo-1-azatricyclo-(7.2.0.0.3.8)undec-2-en-carboxylsyreestere og fremgangsmåde til fremstilling deraf
NO975921D0 (no) Fremstilling av bicykloheksanderivater
PT88545A (pt) Process for the manufacture of benzimidazoline-2-oxo-1-carboxylic acid derivative compounds
FI905930A7 (fi) Menetelmä uusien, farmakologisesti käyttökelpoisten bispilokarpiinihapon esterijohdannaisten valmistamiseksi
MA18516A1 (fr) Procede de preparation de nouveaux derives acetyleniques de l'androst-a-ene
FI890678A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
MA21499A1 (fr) Procede de preparation de nouveaux derives de la i-arylsylfonyl 2-pyrrolidinone.
FI910159A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 9a-hydroksi-3-okso- 4,24(25)-stigmastadieeni-26-happojohdannaisten valmistamiseksi
FR2628421B1 (fr) Procede de preparation des derives de 1,4-dihydropyridine et nouveaux intermediaires utiles pour cette preparation
FI925546A7 (fi) Amidiliittyneitä pyridyylihappojohdannaisia leukotrieeniin liittyvien sairauksien hoitamiseksi
FI900665A0 (fi) Derivat av 3-pyroglutamyl-tiatsolidin -4-karboxylsyra och deras farmakologiska egenskaper.
FR2611201B1 (fr) Intermediaires de tetrazole et procede de preparation de derives antihypercholesterolemiques du tetrazole
NO176607C (no) Fremgangsmåte for fremstilling av merkede 3-aroyl-2-oksindol-1-karboksamider
FI922268L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten N-difenyylialkyylialkoksisubstituoitujen 3-piperidiinikarboksyylihappojohdannaisten valmistamiseksi
IT1113738B (it) Procedimento per la preparazione di derivati di acido 1,5-ciclo-esadien carbossilico sostituito e prodotto ottenuto
FI931893L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 7,8-dihydroksi-1,2,5-oksa-, tia- ja seleenidiatsolo/3,4-f/kinoksaliinijohdannaisten valmistamiseksi
PT88578A (pt) Process for the manufacture of 2,6-methanopyrrolo-3-benzazocines of intermediates useful for their manufacture and of pharmaceutical compositions containing them
IT1210968B (it) Derivati eterociclici dell'acido acetico e procedimento per la loro preparazione.